Introduction
============

Accumulation of lipids in hepatocytes occurs in NAFLD which is seen in association with various diseases, toxins, and drugs. There is evidence that level hepatic enzymes change significantly. Steatosis is the first stage of NAFLD which can convert to nonalcoholic steatohepatitis (NASH) and finally cirrhosis ([@B1], [@B2]). There is correlation between cirrhosis and liver cancer ([@B3]). Usually, ultrasonography check of liver is diagnostic method for NAFLD. However, precious diagnosis requires liver biopsy ([@B4]). Several attempts are done to find noninvasive biomarkers for NAFLD. Proteomics, genomics, metabolomics, and bioinformatics are used to analyze molecular aspect of NAFLD ([@B5]-[@B8]). In one study cytokeratin-18 fragment level is introduced as noninvasive biomarker for NAFLD while in the other investigation a large number of biomarkers are tabulated and introduced to diagnose NAFLD ([@B9], [@B10]).

PPI network analysis is used to interact large numbers of proteins (or genes) in a network to provide possible screening tool. In this approach few genes among interacted genes play critical role to construct the network, and therefore have many connection with the other elements of the network. These types of genes are known as hubs. The other types of important elements of network are known as bottlenecks. The common hubs and bottlenecks are famous as hub-bottlenecks ([@B11], [@B12]). Gene ontology is useful method to identify biological terms related to investigate genes. In this regard, molecular function, biological processes, cellular component, and biochemical pathways as molecular features related to the query genes recognize ([@B13]). In this study, gene expression profiles of NAFLD (steatosis stage) patients are compared with control (data are retrieved from GEO) and the significant DEGs are included into interactome to find critical genes which are involved in NAFLD. Gene ontology is used to identify biological terms related to NAFLD. The finding can be considered to determine possible diagnostic and therapeutic biomarkers.

Methods
=======

Gene expression profiles of 14 non-alcoholic fatty liver disease (NAFLD) stage steatosis patients and 14 controls, series GSE48452, GPL11532 were obtained from GEO. Demography of samples are tabulated in the [table 1](#T1){ref-type="table"} ([@B14]). Liver biopsy samples were analyzed by array-based DNA methylation and mRNA expression. Profiles were compared via boxplot analysis and top 250 significant DEGs were considered for more analysis. The characterized DEGs with fold change more than 1.5 were determined and included in PPI network. The query DEGs and 100 added relevant genes were included in network to constructed PPI network by using STRING database and Cytoscape software ([@B15], [@B16]). The network was analyzed via Network analyzer plugin of Cytoscpe software. Biological terms relative to the query DEGs were determined and clustered by ClueGO ([@B17]). Critical DEGs based on network analysis and GO enrichment were determined. For more understanding a PPI network including the critical DEGs and their direct neighbors was built.

Results
=======

Gene expression profiles of 14 steatosis samples and 14 controls are analyzed via boxplot analysis. As it is shown in the [figure 1](#F1){ref-type="fig"} data obey from median centered distribution, therefore they are statistically comparable.

![Boxplot presentation of gene expression profiles of 14 steatosis patients and 14 controls](GHFBB-12-131-g001){#F1}

![LogFC 31 DEGs including 20 up-regulated and 11 down-regulated ones is illustrated](GHFBB-12-131-g002){#F2}

Among 250 top significant DEGs, 31 individuals were characterized and included in network construction. In [figure 2](#F2){ref-type="fig"}, the 31 DEGs and their LogFC are shown. In this figure, it is appeared that there are 20 up -- regulated and 11 down -- regulated DEGs. The network was built by 31 query DEGs and 100 added relevant ones. As it is illustrated in [figure 3](#F3){ref-type="fig"}, [4](#F4){ref-type="fig"} DEGs were not recognized and the network was constructed by 127 nodes and 1576 edges.

![The main connected component including 120 nodes and 1576 edges is shown. The nodes are layout based on degree value. PRKCE, OXT, and ANXA2, the query DEGs are shown in the left side of figure](GHFBB-12-131-g003){#F3}

![Nine groups including 27 terms relevant to the 31 DEGs are shown](GHFBB-12-131-g004){#F4}

Numbers of 7 nodes were isolated and the main connected component contains 120 nodes. Biological terms relative to the 31 DEGs are presented in the [figure 4](#F4){ref-type="fig"}. The 27 terms are grouped in 9 classes. Details of [figure 4](#F4){ref-type="fig"} and additional information are tabulated in [table 2](#T2){ref-type="table"}. As it is shown in this table only 9 genes among 31 DEGs are involved in the biological terms. As it is shown in the [figure 3](#F3){ref-type="fig"} and [table 2](#T2){ref-type="table"} three important DEGs are included PRKCE, OXT, and ANXA2. These three DEGs and their direct neighbors are shown in [figure 5](#F5){ref-type="fig"}.

![Network including PRKCE, OXT, and ANXA2 and their direct neighbors is illustrated. The nodes are layout based on degree value. Bigger size is corresponded to high value of degree. Color from blue to red refers to increment of degree value](GHFBB-12-131-g005){#F5}

![Boxplot analysis of gene expression profiles of 4 control in comparison with 4 steatosis patients samples](GHFBB-12-131-g006){#F6}

Considering important role of oxytocin in our study and well-known function of this hormone in females, expression change of OXT in male patients and control was investigated. Therefore, possible bias of sex effect is considered. It was appeared that fold change of oxytocin was equal to 3.76 (LogFC = 1.91) and this hormone was the top deregulated DEGs. Demography of samples and boxplot analysis are shown in [table 3](#T3){ref-type="table"} and [figure 6](#F6){ref-type="fig"}.

###### 

Demography of controls and patients    (14) 

  R    Accession    Group       Sex      Age    Bmi
  ---- ------------ ----------- -------- ------ --------
  1    GSM1178970   Control     male     53     25.8
  2    GSM1178971   Control     female   51     23.6
  3    GSM1178972   Control     male     77\*   26.9\*
  4    GSM1178973   Control     male     23     26.6
  5    GSM1178974   Control     male     80     25.8
  6    GSM1178977   Control     male     68     26.4
  7    GSM1178978   Control     female   45     20.1
  8    GSM1178979   Control     female   44     29.4
  9    GSM1178986   Steatosis   female   46     43.5
  10   GSM1178988   Steatosis   female   24     51.9
  11   GSM1178989   Steatosis   female   32     48.6
  12   GSM1178993   Steatosis   female   38\*   42.4\*
  13   GSM1178998   Control     female   28     17.4
  14   GSM1178999   Steatosis   female   47     56
  15   GSM1179009   Control     female   38\*   30.0\*
  16   GSM1179010   Control     female   42     23.3
  17   GSM1179011   Steatosis   male     61     40.3\*
  18   GSM1179018   Control     female   73     21
  19   GSM1179021   Steatosis   male     38\*   55.5\*
  20   GSM1179023   Steatosis   female   33     40.9
  21   GSM1179024   Control     female   44     24.9
  22   GSM1179025   Steatosis   female   39\*   53.6\*
  23   GSM1179027   Steatosis   male     47\*   47.9\*
  24   GSM1179029   Steatosis   male     65     43.7
  25   GSM1179031   Control     female   60\*   30.8\*
  26   GSM1179034   Steatosis   female   42     49.6
  27   GSM1179037   Steatosis   female   32     60.2
  28   GSM1179040   Steatosis   female   39\*   41.8\*

###### 

Numbers of 27 terms relevant to the 31 DEGs are clustered in the 9 groups. %G/T refers to percentage of genes that are involved in term. Gene column shows the gene which participates in the related term

  R    GO Term                                                                                  Ontology Source                                         Group   \% G/T     Gene
  ---- ---------------------------------------------------------------------------------------- ------------------------------------------------------- ------- ---------- ---------
  1    **pyruvate secondary active transmembrane transporter activity**                         GO_MolecularFunction-EBI-QuickGO-GOA_20.11.2017_00h00   1       100        SLC16A7
  2    **CSAD decarboxylates 3-sulfinoalanine to hypotaurine**                                  REACTOME_Reactions_20.11.2017                           2       100        CSAD
  3    **HSD17B11 dehydrogenates EST17b to E1**                                                 3                                                       100     HSD17B11   
  4    **STARD5 binds DCA, LCA**                                                                4                                                       100     STARD5     
  5    **Golgi to plasma membrane CFTR protein transport**                                      GO_BiologicalProcess-EBI-QuickGO-GOA_20.11.2017_00h00   5       50         KRT18
  6    **Defective ABCC6 causes pseudoxanthoma elasticum (PXE)**                                REACTOME_Pathways_20.11.2017                            6       100        ABCC6
  7    Defective ABCC6 does not transport organic anion from cytosol to extracellular region    REACTOME_Reactions_20.11.2017                                              
  8    Oxytocin receptor bind oxytocin                                                          7                                                       50      OXT        
  9    **regulation of hindgut contraction**                                                    GO_BiologicalProcess-EBI-QuickGO-GOA_20.11.2017_00h00                      
  10   positive regulation of hindgut contraction                                               100                                                                        
  11   DAG stimulates protein kinase C-delta                                                    8                                                       50      PRKCE      
  12   **TRAM-dependent toll-like receptor signaling pathway**                                                                                                             
  13   TRAM-dependent toll-like receptor 4 signaling pathway                                                                                                               
  14   positive regulation of cellular glucuronidation                                          100                                                                        
  15   Expression of annexin A2                                                                 REACTOME_Reactions_20.11.2017                           9       50         ANXA2
  16   negative regulation of development of symbiont involved in interaction with host         GO_BiologicalProcess-EBI-QuickGO-GOA_20.11.2017_00h00   100                
  17   positive regulation of low-density lipoprotein particle clearance                                                                                                   
  18   catabolism by organism of protein in other organism involved in symbiotic interaction                                                                               
  19   catabolism by host of substance in symbiont                                                                                                                         
  20   metabolism by host of symbiont macromolecule                                                                                                                        
  21   metabolism by host of symbiont protein                                                                                                                              
  22   **negative regulation of low-density lipoprotein particle receptor catabolic process**   50                                                                         
  23   catabolism by host of symbiont macromolecule                                             100                                                                        
  24   positive regulation of low-density lipoprotein particle receptor binding                                                                                            
  25   positive regulation of low-density lipoprotein receptor activity                                                                                                    
  27   catabolism by host of symbiont protein                                                                                                                              
  27   positive regulation of receptor-mediated endocytosis involved in cholesterol transport   50                                                                         

###### 

Demography of 4 male patients and 4 male controls which their gene expression profiles are compared is shown

  R    Accession    Group       Sex    Age    Bmi
  ---- ------------ ----------- ------ ------ --------
  1    GSM1178970   Control     male   53     25.8
  3    GSM1178972   Control     male   77\*   26.9\*
  4    GSM1178973   Control     male   23     26.6
  6    GSM1178977   Control     male   68     26.4
  17   GSM1179011   Steatosis   male   61     40.3\*
  19   GSM1179021   Steatosis   male   38\*   55.5\*
  23   GSM1179027   Steatosis   male   47\*   47.9\*
  24   GSM1179029   Steatosis   male   65     43.7

Discussion
==========

Gene profile analysis can provide useful information about molecular mechanism of diseases (18, 19). In this study network analysis is used to screen significant DEGs which differentiated steatosis stage of NAFLD patients from controls. As it is shown in the [figure 1](#F1){ref-type="fig"}, statistically samples are comparable because distribution of data is median centric. Therefore, more investigations about samples are possible. As it is shown in [figure 2](#F2){ref-type="fig"}, up-regulation is prominent relative to down-regulation in NAFLD. Numbers of 20 DEGs are up-regulated while 11 down-regulated genes are represented. However, PRDM10, PIK3CA, GAPDH, ALB, SRC, and TP53 are the hubs of the network but PRKCE, OXT, and ANXA2 the query DEGs play significant roles in the PPI network. PRKCE and OXT are upregulated genes while ANXA2 is down regulated one (see [figure 2](#F2){ref-type="fig"}). In [figure 3](#F3){ref-type="fig"}, positions of these three DEGs relative to the other query DEGs are layout and illustrated. The other query DEGs are characterized with weak centrality role in the network. Among 31 DEGs, seven ones containing BEAN1, CCDC82, GOLGA8O, GOLGA8T, HAPLN4, RAPGEFL1, and STARD5 were not included in the network and remained as isolated nodes. GO analysis indicates that 9 DEGs are involved in the 27 biological terms which are clustered in the 9 groups (see [figure 4](#F4){ref-type="fig"} and [table 2](#T2){ref-type="table"}). Group 9: negative regulation of low-density lipoprotein particle receptor catabolic process is the largest group including 13 biological terms. The second and third larger groups (groups 8 and 7) are TRAM-dependent toll-like receptors signaling pathway (including 4 terms) and regulation of hindgut contraction (containing 3 terms), respectively. ANXA2, PRKCE, and OXT are complicated in the groups 9, 8, and 7, respectively. These three DEGs are involved in 20 terms (74% of all biological Terms). As it is shown in the [figure 5](#F5){ref-type="fig"}, 77 nodes (64% of PPI network nodes) are directly linked to PRKCE, OXT, and ANXA2. It seems ANXA2, PRKCE, and OXT are central DEGs among 31 query DEGs which their deregulation is functionally significant event in NAFLD.

Since oxytocin is a well-known female hormone and there are no sufficient documents about its role in men, we design another analysis that was resulted from comparison between male patients and control (see [table 3](#T3){ref-type="table"} and [figure 6](#F6){ref-type="fig"}). In this analysis OXT appeared as the top DEGs based on fold change. Therefore, presence of oxytocin among three important DEGs in NAFLD is depended to both male and female patients.

Four biological terms in group 9 are about regulation of low-density lipoprotein (LDL). LDL is a cholesterol-carrying agent in human plasma which LDL receptor regulates its plasma level. Investigation showed that raising cholesterol content of liver hepatocytes leads to fall of LDL receptors in liver which causes increment of LDL level of plasma. This process is seen after digestion of diets rich in saturated fat and cholesterol ([@B20]). It seems that deregulation of ANXA2 effects on storage of fat in lever via deregulation of clearance of plasma cholesterol. Sun *et al*. reported that there is correlation between low-density lipoprotein cholesterol and NAFLD prevalence ([@B21]). However, role of ANXA2 in NAFLD is reported previously, here it is introduced as the top related gene in NAFLD (especially steatosis stage).

Positive regulation of cellular glucuronidation is one of group 8 biological process. Glucuronidation is a major biochemical pathway that plays role in cellular detoxification. In this pathway, the highly hydrophilic glucuronide group transfers to hydrophobic substrates which are less toxic and can be exerted easily relative to the initial substances ([@B22]). Role of this protective process was studied in drug metabolism of NAFLD patients ([@B23]). It can be concluded that up-regulation of PRKCE which promotes positive regulation of cellular glucuronidation is a protecting activity in NAFLD.

Regulation of hindgut contraction is a term which is related to oxytocin. It is reported that positive regulation of hindgut (the posterior part of the alimentary canal, including the rectum, and the large intestine) is appositive regulation of smooth muscle which positively regulates hindgut contraction. This terms is responsible for positive regulation of digestion (https://www.ebi.ac.uk/QuickGO/term/GO:0060450). In conclusion up-regulation of OXT stimulates digestion in steatosis stage of NAFLD.

Precious analysis revealed that ANXA2, PRKCE, and OXT are three important genes that are involved in steatosis stage of NAFLD. Significant expression change, participation in prominent biochemical pathways, and large number of connections with the other genes imply that these DEGs be considered as critical genes relative to NAFLD. It can be suggested that suitable quantity profiles of ANXA2, PRKCE, and OXT be validated to manage steatosis stage of NAFLD.
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